CPMI CLINICAL PHARMACOLOGY OF MIAMI

Serial Number 97855931
Registration 7453584
700

Registration Progress

Application Filed
Mar 24, 2023
Under Examination
Approved for Publication
May 7, 2024
Published for Opposition
May 7, 2024
Registered
Jul 23, 2024

Trademark Image

CPMI CLINICAL PHARMACOLOGY OF MIAMI

Basic Information

Serial Number
97855931
Registration Number
7453584
Filing Date
March 24, 2023
Registration Date
July 23, 2024
Published for Opposition
May 7, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 23, 2024
Registration
Registered
Classes
042

Rights Holder

Evolution Research Group, LLC

16
Address
430 Mountain Avenue, Suite 302
New Providence, NJ 07974

Ownership History

Evolution Research Group, LLC

Original Applicant
16
New Providence, NJ

Evolution Research Group, LLC

Owner at Publication
16
New Providence, NJ

Evolution Research Group, LLC

Original Registrant
16
New Providence, NJ

Legal Representation

Attorney
Michael A. Geller

USPTO Deadlines

Next Deadline
1670 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240723)
Due Date
July 23, 2030
Grace Period Ends
January 23, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Jul 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 28, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 28, 2024 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 28, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 28, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 19, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 19, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 19, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 4, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 29, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 29, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 29, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 29, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 18, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 16, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 28, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical and scientific research involving the design and conduct of clinical trials
First Use Anywhere: Jan 17, 2017
First Use in Commerce: Jan 17, 2017

Additional Information

Design Mark
The mark consists of the words "CLINICAL PHARMACOLOGY OF MIAMI" formed in a circle with "CLINICAL PHARMACOLOGY" on the upper half and "OF MIAMI" on the lower half. In the middle is a jagged line depicting an electrocardiogram wave with the initials "CPMI" below.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICAL PHARMACOLOGY"